Aspira Women's Health Inc. (NASDAQ: AWH)
$1.62
+0.0050 ( +0.31% ) 126.7K
Aspira Womens Health Inc is engaged in developing and commercializing diagnostic tests for gynecologic diseases. Its products include OvaSuite which is a portfolio of blood tests that applies proprietary algorithms incorporating patient features; OvaWatch intended for use in assessing the risk of ovarian cancer for women with adnexal masses; and Ova1Plus is a portfolio of blood tests, Ova1Plus is a combination of two FDA-cleared tests for women with pelvic masses who are planned for surgery.
Market Data
Open
$1.62
Previous close
$1.61
Volume
126.7K
Market cap
$20.17M
Day range
$1.33 - $1.64
52 week range
$0.86 - $6.75
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 12 | Jun 14, 2024 |
4 | Insider transactions | 1 | Jun 14, 2024 |
8-k | 8K-related | 12 | Jun 07, 2024 |
4 | Insider transactions | 1 | Jun 03, 2024 |
10-q | Quarterly Reports | 53 | May 15, 2024 |
8-k | 8K-related | 12 | May 15, 2024 |
4 | Insider transactions | 1 | May 14, 2024 |
4 | Insider transactions | 1 | May 14, 2024 |
8-k | 8K-related | 11 | May 14, 2024 |
4 | Insider transactions | 1 | May 06, 2024 |